Literature DB >> 9459645

Natural history of cervicovaginal papillomavirus infection in young women.

G Y Ho1, R Bierman, L Beardsley, C J Chang, R D Burk.   

Abstract

BACKGROUND: Genital human papillomavirus (HPV) infection is highly prevalent in sexually active young women. However, precise risk factors for HPV infection and its incidence and duration are not well known.
METHODS: We followed 608 college women at six-month intervals for three years. At each visit, we collected information about lifestyle and sexual behavior and obtained cervicovaginal-lavage samples for the detection of HPV DNA by polymerase chain reaction and Southern blot hybridization. Pap smears were obtained annually.
RESULTS: The cumulative 36-month incidence of HPV infection was 43 percent (95 percent confidence interval, 36 to 49 percent). An increased risk of HPV infection was significantly associated with younger age, Hispanic ethnicity, black race, an increased number of vaginal-sex partners, high frequencies of vaginal sex and alcohol consumption, anal sex, and certain characteristics of partners (regular partners having an increased number of lifetime partners and not being in school). The median duration of new infections was 8 months (95 percent confidence interval, 7 to 10 months). The persistence of HPV for > or =6 months was related to older age, types of HPV associated with cervical cancer, and infection with multiple types of HPV but not with smoking. The risk of an abnormal Pap smear increased with persistent HPV infection, particularly with high-risk types (relative risk, 37.2; 95 percent confidence interval, 14.6 to 94.8).
CONCLUSIONS: The incidence of HPV infection in sexually active young college women is high. The short duration of most HPV infections in these women suggests that the associated cervical dysplasia should be managed conservatively.

Entities:  

Keywords:  Adolescents; Adolescents, Female; Age Factors; Americas; Biology; Cross Sectional Analysis; Demographic Factors; Developed Countries; Diseases; Epidemiology; Health; Hpv; New Jersey; North America; Northern America; Population; Population Characteristics; Public Health; Research Methodology; Research Report; Risk Factors; United States; Viral Diseases; Women; Youth--women

Mesh:

Year:  1998        PMID: 9459645     DOI: 10.1056/NEJM199802123380703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  504 in total

1.  Association of oncogenic human papillomavirus DNA with high grade cervical intraepithelial neoplasia: the role of cigarette smoking.

Authors:  S F Derchain; C M Roteli-Martins; K J Syrjänen; H J de Abreu; E Z Martinez; V A Alves
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

2.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 3.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Cervical cancer prevention for all Canadians.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1999-02       Impact factor: 3.275

5.  Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?

Authors:  L Brabin
Journal:  BMJ       Date:  2001-08-18

6.  Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex.

Authors:  Eric J Enemark; Arne Stenlund; Leemor Joshua-Tor
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

7.  Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.

Authors:  Kevin L Karem; Alysia C Poon; Cynthia Bierl; Rosane Nisenbaum; Elizabeth Unger
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

8.  Prevalence of infection with carcinogenic human papillomavirus among older women.

Authors:  John W Sellors; Tina L Karwalajtys; Janusz A Kaczorowski; James B Mahony; Alice Lytwyn; Sylvia Chong; Joanna Sparrow; Attila Lorincz
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

9.  Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18.

Authors:  Hai-Bo Liu; Pankaj Kumar Chaturvedi; Gantumur Battogtokh; Hyo Joo Bang; In-Wook Kim; Yong-Wan Kim; Kye-Shin Park; Woong Shick Ahn
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

10.  Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11.

Authors:  Manjula Singh; Deepshi Thakral; Hemanta Kumar Kar; Narayan Rishi; Prafulla Kumar Sharma; Dipendra Kumar Mitra
Journal:  Virusdisease       Date:  2017-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.